SIG
BSX icon

Stonegate Investment Group’s Boston Scientific BSX Stock Holding History

Stonegate Investment Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$653K Buy
6,692
+36
+0.5% +$3.73K 0.02% 219
2025
Q2 		$715K Sell
6,656
-464
-7% -$46.9K 0.02% 201
2025
Q1 		$718K Sell
7,120
-707
-9% -$71.2K 0.02% 185
2024
Q4 		$699K Buy
7,827
+126
+2% +$11.1K 0.02% 182
2024
Q3 		$645K Buy
7,701
+534
+7% +$42.1K 0.02% 204
2024
Q2 		$552K Buy
7,167
+17
+0.2% +$1.24K 0.02% 217
2024
Q1 		$490K Sell
7,150
-1,490
-17% -$95.8K 0.02% 221
2023
Q4 		$499K Sell
8,640
-2,343
-21% -$125K 0.02% 209
2023
Q3 		$580K Sell
10,983
-51
-0.5% -$2.67K 0.02% 192
2023
Q2 		$597K Buy
11,034
+371
+3% +$19.4K 0.02% 194
2023
Q1 		$533K Buy
10,663
+458
+4% +$21.6K 0.02% 202
2022
Q4 		$472K Buy
10,205
+904
+10% +$39.1K 0.02% 207
2022
Q3 		$360K Buy
9,301
+2,165
+30% +$86.9K 0.02% 209
2022
Q2 		$266K Buy
7,136
+2,472
+53% +$101K 0.01% 244
2022
Q1 		$207K Sell
4,664
-540
-10% -$23.4K 0.01% 242
2021
Q4 		$221K Buy
+5,204
New +$219K 0.01% 238

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stonegate Investment Group's BSX Position: Q3 2025 in Review

Stonegate Investment Group increased its Boston Scientific (BSX) stake by 0.54% in Q3 2025, buying an estimated $3.73K and bringing the position to 6,692 shares worth $653K. The position accounts for 0.02% of the portfolio, ranked #219.

Stonegate Investment Group first reported a position in BSX in Q4 2021 and has held it in 16 quarters since. The position peaked at $718K in Q1 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Stonegate Investment Group held 6,692 shares of Boston Scientific worth $653K as of Q3 2025.
  • Stonegate Investment Group bought 36 Boston Scientific shares in Q3 2025, an estimated $3.73K.
  • Boston Scientific made up 0.02% of Stonegate Investment Group's portfolio in Q3 2025, its #219 holding.
  • Stonegate Investment Group first reported a position in Boston Scientific in Q4 2021 and has held it in 16 quarters since.
  • Stonegate Investment Group's Boston Scientific position peaked at $718K in Q1 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Stonegate Investment Group's 13F filing for Q3 2025, filed 3 Nov 2025.